ArticleBrain communications2021

K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy.

Natasha E Schoeler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.